Literature DB >> 19027297

11-Phenyl-[b,e]-dibenzazepine compounds: novel antitumor agents.

Raed A Al-Qawasmeh1, Yoon Lee, Ming-Yu Cao, Xiaoping Gu, Stéphane Viau, Jeff Lightfoot, Jim A Wright, Aiping H Young.   

Abstract

A series of 11-phenyl-[b,e]-dibenzazepine compounds were synthesized and shown to be inhibitors of tumor cell proliferation with IC(50) values ranging from submicromolar to micromolar concentrations. Flow cytometric analyses of several active compounds demonstrated inhibition of cell cycle progression at the G(0)-G(1) phase transition resulting in G(0)-G(1) arrest.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027297     DOI: 10.1016/j.bmcl.2008.11.001

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  5-[(1-Benzyl-1H-1,2,3-triazol-4-yl)meth-yl]-5H-dibenzo[b,f]azepine.

Authors:  B C Manjunath; K S Vinay Kumar; S Madan Kumar; M P Sadashiva; N K Lokanath
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-11-13

2.  Iminostilbene, a novel small-molecule modulator of PKM2, suppresses macrophage inflammation in myocardial ischemia-reperfusion injury.

Authors:  Shan Lu; Yu Tian; Yun Luo; Xudong Xu; Wenxiu Ge; Guibo Sun; Xiaobo Sun
Journal:  J Adv Res       Date:  2020-09-09       Impact factor: 10.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.